CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
171228-51-6 | 泊沙康唑杂质17 | posaconazole impurity 17 | | | | |
17123-20-5 | | 2,5-bis(4-methylanilino)-3,6-dichloro-1,4-benzoquinone | | | | |
17123-21-6 | | 2,5-bis(4-methoxyanilino)-3,6-dichloro-1,4-benzoquinone | | | | |
17123-28-3 | | sarcosyl-l-phenylalanine | | | | |
17123-30-7 | | gly-phe-ala | C14H19N3O4 | 293.32 | | |
17123-43-2 | | sodium dihydroxyethylglycine | | | | |
17123-60-3 | | 2-methyl-1,5-hexadien-3-ol | | | | |
17123-63-6 | 2,5-二甲基-1,5-己二烯-3-醇 | 2,5-dimethyl-1,5-hexadien-3-ol | | | | |
17123-74-9 | | o-hydroxy-hydrocinnamic aci acetate | | | | |
17123-82-9 | | 1-(3-(4-chlorophenyl)-1-oxo-2-propenyl)-piperidin | | | | |
171230-55-0 | | doyle dirhodium catalyst - rh2(4S-mppim)4 | C60H66N10O16Rh2 | 1389.05 | | |
171230-81-2 | (R)-2-((叔丁基二甲基甲硅烷基)氧基)丙酸甲酯 | (R)-methyl 2-((tert-butyldimethylsilyl)oxy)propanoate | | | | |
171235-71-5 | | tapi-1(random configuration) | | | | |
171237-36-8 | | hepatic leukemia factor | | | | |
17124-24-2 | | n(6)-methoxyadenine | | | | |
17124-29-7 | | (o-phenylenebis(oxy-2-butynylene))bis(trimethyl-ammoniu diiodide | | | | |
17124-30-0 | | (o-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-31-1 | | (o-phenylenebis(oxy-2-butynylene))bis(triethyl-ammoniu diiodide | | | | |
17124-32-2 | | (p-phenylenebis(oxy-2-butynylene))bis(ethyldimethyl-ammoniu diiodide | | | | |
17124-33-3 | | (m-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-34-4 | | (p-phenylenebis(oxy-2-butynylene))bis(trimethyl-ammoniu diiodide | | | | |
17124-35-5 | | (m-phenylenebis(oxy-2-butynylene))bis(ethyldimethyl-ammoniu diiodide | | | | |
17124-36-6 | | (p-phenylenebis(oxy-2-butynylene))bis(diethylmethyl-ammoniu diiodide | | | | |
17124-37-7 | | (p-phenylenebis(oxy-2-butynylene))bis(triethyl-ammoniu diiodide | | | | |
17124-56-0 | | 3-(6-chloro-2-oxo-benzooxazol-3-yl)-propionic acid | | | | |
17124-68-4 | | 2-(2-aminoethyl)-1,3-dimethyl-2-thio-pseudoure dihydrobromide | | | | |
17124-71-9 | | 2-(2-aminoethyl)-1-(1-naphthyl)-2-thio-pseudoure dihydrobromide | | | | |
17124-73-1 | | 2-(2-(diethylamino)ethyl)-2-thio-pseudoure dihydrochloride | | | | |
17124-74-2 | | 2-(2-(diethylamino)ethyl)-1-phenyl-2-thio-pseudoure dihydrobromide | | | | |
17124-75-3 | | 2-((2-(diethylamino)ethyl)thio)-2-imidazolin dihydrochloride | | | | |
17124-80-0 | | 2-(1 h -benzoimidazol-2-ylsulfanyl)-ethylamine | | | | |
17124-82-2 | | | | | | |
171243-30-4 | 3-氟-5-(三氟甲基)苯甲酰氯 | 3-fluoro-5-(trifluoromethyl)benzoyl chloride | | | | 119℃ |
17125-21-2 | | n-benzyl-beta-bromo-phenethylamin hydrobromide | | | | |
17125-80-3 | 六氟合硅酸(2-)钡(1:1) | Silicate(2-), hexafluoro-barium (1:1) | Ba·F6Si | | | |
17125-84-7 | | [(ethylenedinitrilo)tetraacetato]-palladate(2- dihydrogen | | | | |
171258-70-1 | | n-(((diphenylmethyl)amino)carbonyl)-2-pyridinecarboxamid | | | | |
171258-71-2 | | n-(((diphenylmethyl)amino)carbonyl)-2-phenyl-4-quinolinecarboxamid | | | | |
171258-72-3 | | 1,2-dihydro-n-(((diphenylmethyl)amino)carbonyl)-2-oxo-4-quinolinecarboxamid | | | | |
171258-73-4 | | n-(((diphenylmethyl)amino)carbonyl)-4-pyridinecarboxamid monohydrochloride | | | | |
171258-74-5 | | n-(((diphenylmethyl)amino)carbonyl)-3-pyridinecarboxamid monohydrochloride | | | | |
171258-75-6 | | n-(((diphenylmethyl)amino)carbonyl)-2-quinolinecarboxamid monohydrochloride | | | | |
171259-64-6 | | l-proline, 1-((3-beta,20-beta)-3-(((S)-6-deoxy-2-o-((S)-6-deoxy-6-(2-(methoxyca | | | | |
171259-65-7 | | l-aspartic acid, n-(1-o-((3-beta,20-beta,29(S))-29-((3-methoxy-1-(methoxycarbon | | | | |
171259-81-7 | (±)-ampa hydrobromide | | | | | |
17126-44-2 | | dipotassium, (oc-6-11)-cerate(2-hexakis(nitrato-o)- | | | | |
17126-46-4 | | trihydrogen, (oc-6-11)-ferrate(3-hexakis(cyano-c)- | | | | |
17126-62-4 | | ethyl 3-isothiocyanatopropionate | C6H9NO2S | 159.20 | | |
17126-63-5 | | diethyl l-2-isothiocyanatoglutarate | | | | |
17126-65-7 | | ethyl 4-isothiocyanatobutanoate | | | | |